Kiyohide Fujimoto

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer

Makito Miyake, Shunta Hori, Yosuke Morizawa et al. · Neoplasia · 2016 · 232 citations · Full text

Medicine, Cancer Biology, Oncology +17

A case‐control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet

Tomoko Sonoda, Yoshie Nagata, Mitsuru Mori et al. · Cancer Science · 2004 · 182 citations · Full text

Public Health, Oncology, Preventive Medicine +16

Frequent association of p53 gene mutation in invasive bladder cancer.

Kiyohide Fujimoto, Yuki Yamada, Tadao Kakizoe et al. · PubMed · 1992 · 150 citations

Medicine, Genetics, Oncology +15

Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209

Hiroshi Kitamura, Tadashi Tsukamoto, Taro Shibata et al. · Annals of Oncology · 2014 · 138 citations · Full text

Medicine, Oncology, Urology +12